Tal Leibovich-Rivkin

Tal Leibovich-Rivkin is an experienced professional in the biotech industry, currently serving as the COO at DenovAI Biotech. With a background in cancer biology and immunotherapy, Tal has held various leadership positions in research and development at companies such as Ayala Pharmaceuticals, Mitoconix Bio Ltd., and Imanu Immunotherapy Inc. Tal's expertise in immunology and oncology is backed by a Ph.D. from Tel Aviv University and an engineering degree from Ben-Gurion University. Their work focuses on defining research strategies, establishing scientific plans, and leading collaborations within the industry.